Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancer

Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancer

US Patent 9637798 · Granted May 2, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of sensitizing a patient with glioma to a therapeutic agent by administe2020
Methods used to treat cancer2019
Genetic signature of vulnerability to inhibitors of base excision repair (BER) i2019
Genetic signature of vulnerability to inhibitors of base excision repair (BER) i2019
Genetic signature of vulnerability to inhibitors of base excision repair (BER) i2019
Methods of using propentofylline to treat glioma and glioblastoma2018
Method of screening for a compound for inhibitory activity of FN14-tweak interac2017
Methods of identifying and treating glioblastoma2017
FN14 antagonists and therapeutic uses thereof2016
Methods and kits to identify invasive glioblastoma2015
Hydrophilic surface modification of polydimethylsiloxane2011
Cell migration inhibiting compositions and methods and compositions for treating2010